.Nature Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- drug conjugate (ADC) tisotumab vedotin resulted in improved progression-free and total survival, triggering FDA commendation as well as a brand-new treatment possibility for clients.